APA (7th ed.) Citation

Codecasa, L., Toumi, M., D'Ausilio, A., Aiello, A., Da Mele, F., Termini, R., . . . De Lorenzo, S. (2016). PRS31 - Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy. Value in Health, 19(7), A553. https://doi.org/10.1016/j.jval.2016.09.1199

Chicago Style (17th ed.) Citation

Codecasa, LR, et al. "PRS31 - Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy." Value in Health 19, no. 7 (2016): A553. https://doi.org/10.1016/j.jval.2016.09.1199.

MLA (9th ed.) Citation

Codecasa, LR, et al. "PRS31 - Cost-Effectiveness of Adding Bedaquiline To Background Drug Regimens For The Treatment of Multidrug-Resistant And Extensively-Resistant Tuberculosis In Italy." Value in Health, vol. 19, no. 7, 2016, p. A553, https://doi.org/10.1016/j.jval.2016.09.1199.